What does OLES stand for?

Open Label Extension Study (pharmaceutical research)

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Open Linking and Embedding of Objects Official Languages in Education Protocol (Canada) Organic Light-Emitting Polymer Outdoor Leadership and Recreation (San Juan College, New Mexico) Oklahoma Law Enforcement Retirement System Office of Law Enforcement Standards Office of Literacy and Essential Skills (Human Resources and Skills Development Canada) Olivocochlear Lateral Efferent System On-Line Executive Summit One-Line Element Set		Ontario Law Enforcement Training Academy (Toronto, Ontario, Canada) Optimal Lightpath Establishment on Tree Organic Light-Emitting Transistor Office of Law Enforcement Technology Commercialization (National Institute of Justice's Office of Science and Technology program) Otsuka Long Evans Tokushima Fatty Oklahoma Law Enforcement Telecommunications System Office for Low Emission Vehicles (UK) Operation Lifesaver Educational Vehicle (rail safety; Canada) Orbital Life Extension Vehicle (spacecraft) Office de La Langue Francaise (Quebec)

Samples in periodicals archive:

The panel also performed an un-blinded adjudication of the Company's Open Label Extension study employing the same criteria used for the Phase 3 trials with the exception that there were no patients on placebo during the Open Label Extension study.

Savient Provides Update on Pegloticase BLA

Data from the double-blind study and the open label extension study will form the basis of 12-month follow-up information to be used in the FDA biologics license application for marketing approval.

Clinic Roundup

Patients in the placebo and the treatment arms of this study were then enrolled in an open label extension study and received adalimumab every other week plus methotrexate.

5-year RA data on adalimumab added to label

Results from a one-year, open label extension study that included 127 patients support Geodon's longer-term efficacy and tolerability in these patients.

Research Update

Data related to the Company's open label extension study to the Phase II study were reviewed in an oral presentation by Paul Swerdlow, M.

Icagen Announces Presentations Related to Senicapoc at the 2006 ...

Results from a one-year, open label extension study that included 127 patients support Geodon's longer-term efficacy and tolerability in these patients.

Two Studies in Patients With Acute Bipolar Mania Show Rapid and ...

These data, presented this week at the 14th United European Gastroenterology Week (UEGW) in Berlin, Germany, and at the Annual American College of Gastroenterology (ACG) in Las Vegas, Nevada, were part of an open label extension study of patients who participated in the ENACT-2 trial.

TYSABRI(R) Maintained Remission in Patients with Moderate-to-Severe ...

Alexion Also Commences Open Label Extension Study in Arthritis - NEW HAVEN, Conn.

Alexion Completes Enrollment in Phase II Efficacy Study of C5 ...